Search research articles
Contact Us
Filters
Showing results (1-10 of 25) with videos related to
Page
of 3
Sort By:
Bulletin Du Cancer
|
May 19, 2005
[Cardiac dysfunction induced by trastuzumab]
Mario Campone, Emmanuelle Bourbouloux, Pierre Fumoleau
Critical Reviews in Oncology/Hematology
|
July 26, 2005
Taxanes in adjuvant breast cancer setting: which standard in Europe?
Mario Campone, Pierre Fumoleau, Emmanuelle Bourbouloux, et al.
Geriatrie Et Psychologie Neuropsychiatrie Du Vieillissement
|
June 24, 2015
[Cancer screening practices in elderly with dementia]
Guillaume Chapelet, Gilles Berrut, Emmanuelle Bourbouloux, et al.
Bulletin Du Cancer
|
May 19, 2011
[Her2 positive breast cancer: practices]
Mario Campone, Dominique Berton-Rigaud, Emmanuelle Bourbouloux, et al.
Expert Opinion on Pharmacotherapy
|
May 15, 2023
Evaluating everolimus for the treatment of breast cancer
Camille Moreau-Bachelard, Marie Robert, Carole Gourmelon, et al.
Bulletin Du Cancer
|
October 17, 2021
[French translation and adaptation of the "Return to Work Self-Efficacy' Scale - 11 items" in patients diagnosed with a cancer]
Bertrand Porro, Audrey Petit, Emmanuelle Bourbouloux, et al.
Drugs
|
August 26, 2018
An Update on the Clinical Use of CDK4/6 Inhibitors in Breast Cancer
Marie Robert, Jean-Sébastien Frenel, Emmanuelle Bourbouloux, et al.
Expert Opinion on Drug Metabolism & Toxicology
|
December 23, 2018
Pharmacokinetic drug evaluation of abemaciclib for advanced breast cancer
Marie Robert, Jean-Sébastien Frenel, Emmanuelle Bourbouloux, et al.
Expert Review of Anticancer Therapy
|
March 20, 2019
Pertuzumab for the treatment of breast cancer
Marie Robert, Jean-Sébastien Frenel, Emmanuelle Bourbouloux, et al.
Expert Opinion on Pharmacotherapy
|
November 25, 2017
Efficacy of buparlisib in treating breast cancer
Marie Robert, Jean-Sébastien Frenel, Emmanuelle Bourbouloux, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 25) with videos related to
Sort By:
Page
of 3
Bulletin Du Cancer
|
May 19, 2005
[Cardiac dysfunction induced by trastuzumab]
Mario Campone, Emmanuelle Bourbouloux, Pierre Fumoleau
Critical Reviews in Oncology/Hematology
|
July 26, 2005
Taxanes in adjuvant breast cancer setting: which standard in Europe?
Mario Campone, Pierre Fumoleau, Emmanuelle Bourbouloux, et al.
Geriatrie Et Psychologie Neuropsychiatrie Du Vieillissement
|
June 24, 2015
[Cancer screening practices in elderly with dementia]
Guillaume Chapelet, Gilles Berrut, Emmanuelle Bourbouloux, et al.
Bulletin Du Cancer
|
May 19, 2011
[Her2 positive breast cancer: practices]
Mario Campone, Dominique Berton-Rigaud, Emmanuelle Bourbouloux, et al.
Expert Opinion on Pharmacotherapy
|
May 15, 2023
Evaluating everolimus for the treatment of breast cancer
Camille Moreau-Bachelard, Marie Robert, Carole Gourmelon, et al.
Bulletin Du Cancer
|
October 17, 2021
[French translation and adaptation of the "Return to Work Self-Efficacy' Scale - 11 items" in patients diagnosed with a cancer]
Bertrand Porro, Audrey Petit, Emmanuelle Bourbouloux, et al.
Drugs
|
August 26, 2018
An Update on the Clinical Use of CDK4/6 Inhibitors in Breast Cancer
Marie Robert, Jean-Sébastien Frenel, Emmanuelle Bourbouloux, et al.
Expert Opinion on Drug Metabolism & Toxicology
|
December 23, 2018
Pharmacokinetic drug evaluation of abemaciclib for advanced breast cancer
Marie Robert, Jean-Sébastien Frenel, Emmanuelle Bourbouloux, et al.
Expert Review of Anticancer Therapy
|
March 20, 2019
Pertuzumab for the treatment of breast cancer
Marie Robert, Jean-Sébastien Frenel, Emmanuelle Bourbouloux, et al.
Expert Opinion on Pharmacotherapy
|
November 25, 2017
Efficacy of buparlisib in treating breast cancer
Marie Robert, Jean-Sébastien Frenel, Emmanuelle Bourbouloux, et al.
Page
of 3